SwipeRx
- Company typePrivate
- Founded2012
- HeadquartersSingapore, Singapore
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What SwipeRx does
SwipeRx, the consumer-facing brand of Singapore-incorporated mClinica Pte. Ltd., is a mobile-first platform that connects pharmaceutical manufacturers, retail pharmacies, and pharmacy professionals across Southeast Asia. The company operates two core products: the SwipeRx App, a community and professional development platform serving 300,000+ pharmacy professionals with accredited CPD education, news, peer collaboration, case reporting, a drug directory, and adverse event reporting; and SwipeRx Belanja, a B2B e-commerce platform primarily for Indonesia that enables retail pharmacies to procure medicines and supplies with competitive pricing, promotions, flexible credit, and free shipping. The ecosystem is augmented by the SwipeRx Reward Pass loyalty program (Bronze through Special Cashback tiers), a Welcome Cashback onboarding incentive, and Misi Belanja shopping mission challenges, all of which deepen transaction frequency and retention.
The company earns revenue primarily through transaction-based markups on B2B commerce through SwipeRx Belanja and through enterprise partnerships with major pharmaceutical companies (Pfizer, Bayer, GSK, AstraZeneca, Novartis, Roche, Kalbe, Novo Nordisk, Haleon, Reckitt, J&J, Sanofi, Takeda, Merck, and others) that leverage the platform for marketing, education, and distribution to 50,000+ retail pharmacies. A secondary revenue and influence channel comes from partnerships with global health organizations and government health ministries (WHO, Gates Foundation, World Bank, USAID, CHAI, The Global Fund, and ministries of health in Indonesia, Philippines, Thailand, Vietnam, and Cambodia). SwipeRx employs 251–500 staff, is headquartered in Singapore with an Indonesian operating entity (PT Teknologi Medika Pratama in Jakarta), and has raised $37 million in disclosed venture funding led by MDI Ventures, with strategic capital from Sanofi Global Health Unit, Cercano, J&J Impact Ventures, Gates Foundation, M3 Inc., and ARKRAY.
SwipeRx firmographics
Firmographics- Name
- SwipeRx
- Legal name
- mClinica Pte. Ltd.
- Website
- https://www.swiperxapp.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
SwipeRx industry classification
Industry- Product category
- Pharmacy B2B Commerce Platform
- NAICS
- Pharmacies and Drug Retailers (45611)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- B2B Marketplaces & Wholesale Platforms (BPAMAGAD)
- akta.pro secondary industries
- 340B Program Administration & Contract Pharmacy Services (HLAFALAL), Discount Drugstores with Clinics (Retail Health Clinics) (CRAEAHAE)
Keywords
Where SwipeRx is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices2 records
Markets served
SwipeRx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- B2B Commerce Transaction Fees: SwipeRx charges pharmacies for procurement of medicines and pharmacy supplies through the SwipeRx Belanja platform. The platform offers competitive pricing, promotions, and free shipping as incentives. Revenue is generated from the mark-up on products sold to pharmacies.
- Pharmaceutical Company Partnerships: SwipeRx partners with pharmaceutical companies (Pfizer, Bayer, GSK, AstraZeneca, Novartis, etc.) for marketing, distribution, and educational content. Revenue likely comes from listing fees, promotional placements, and co-marketing arrangements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Tiered loyalty program based on verified points accumulation |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
SwipeRx product offering
Product offeringCore offering
SwipeRx operates a mobile-first B2B commerce and professional community platform connecting 300,000+ pharmacy professionals and 50,000+ retail pharmacies across Southeast Asia with pharmaceutical manufacturers and suppliers. Its SwipeRx Belanja B2B e-commerce platform enables pharmacies to procure medicines and supplies with competitive pricing, promotions, flexible payment, and delivery, while the broader app delivers accredited CPD education, industry news, drug directory, case reporting, adverse event reporting, and peer collaboration for pharmacists.
Product overview
SwipeRx operates as a platform-plus-modules architecture centered on two core products: the SwipeRx App (a mobile community and B2B commerce platform serving pharmacy professionals across Southeast Asia) and SwipeRx Belanja (a dedicated B2B e-commerce platform for pharmacies in Indonesia). The ecosystem is enhanced by loyalty and promotional modules including SwipeRx Reward Pass (a multi-tiered loyalty program), Welcome Cashback (new user incentive), and Misi Belanja (shopping mission challenges). The platform connects over 300,000 pharmacy professionals and 50,000+ retail pharmacies, offering CPD education, drug directory, B2B commerce, adverse event reporting, and research survey capabilities.
Differentiator
Problem solved
Functional benefit
Products and services
- SwipeRx App The primary mobile application (iOS and Android) serving as a community platform and B2B commerce solution for pharmacy professionals across Southeast Asia, connecting 300,000+ pharmacy professionals and 50,000+ retail pharmacies with features including accredited CPD education modules, news and announcements, collaboration with colleagues, case reporting and referrals, research surveys, drug directory, adverse event reporting, and B2B commerce.
- SwipeRx Belanja A B2B e-commerce platform specifically for retail pharmacies in Indonesia, enabling online procurement of medicines and pharmacy supplies with competitive pricing, promotional discounts, free shipping, flexible payment options, and delivery services.
- SwipeRx Reward Pass A points-based loyalty program that allows pharmacy members to accumulate verified points through procurement transactions and redeem them for rewards. Features multiple membership tiers (Bronze, Silver, Gold, Platinum, Titanium, Special Cashback) with points earned at Rp50 per Rp10,000 transaction (after tax and after delivery) and a Special Cashback tier offering 10% cashback up to 5 million points for selected pharmacies.
Quantifiable outcome
- 150,000+ pharmacy professionals educated through digital CPD programs
- +2 more outcomes
Companies that use SwipeRx
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
SwipeRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
SwipeRx partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered core.
- PfizercorePharmaceutical company partner. Pfizer leverages SwipeRx platform for marketing, education, and distribution reach to pharmacy professionals across Southeast Asia.
- BayercorePharmaceutical company partner leveraging SwipeRx platform for pharmacy network access.
- GSKcorePharmaceutical company partner on SwipeRx platform.
- HaleoncoreConsumer healthcare company partner on SwipeRx platform.
- AstraZenecacorePharmaceutical company partner on SwipeRx platform.
- NovartiscorePharmaceutical company partner on SwipeRx platform.
- RochecorePharmaceutical company partner on SwipeRx platform.
- KalbecoreIndonesian pharmaceutical company partner on SwipeRx platform.
- Novo NordiskcorePharmaceutical company partner on SwipeRx platform.
- ReckittcoreConsumer health company partner on SwipeRx platform.
- Gates FoundationcoreGlobal health foundation partnership supporting public health initiatives through pharmacy networks in Southeast Asia.
- World Health Organization (WHO)coreWHO partnership supporting global health initiatives and pharmacy professional development.
- World BankcoreInternational development organization partnership supporting healthcare initiatives.
- USAIDcoreUS government development agency partnership for healthcare programs.
- The Global FundcoreInternational financing organization partnership for health programs.
- CHAI (Clinton Health Access Initiative)coreHealth access organization partnership supporting affordable healthcare.
- Indonesia Ministry of Health (Kemenkes)coreGovernment health ministry partnership for pharmacy regulation and public health initiatives in Indonesia.
- Philippines Department of Health (DOH)coreGovernment health department partnership for pharmacy initiatives in the Philippines.
- Thailand Ministry of Public Health (MOPH)coreGovernment health ministry partnership for pharmacy initiatives in Thailand.
- Vietnam Ministry of Health (MOH)coreGovernment health ministry partnership for pharmacy initiatives in Vietnam.
- Cambodia Ministry of Health (MOH)coreGovernment health ministry partnership supporting One Health for Cambodia project.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
SwipeRx competitors and assessment
Company assessmentDirect peers
- Halodoc: Indonesian digital health platform offering teleconsultation, e-pharmacy and medicine delivery to consumers. Directly comparable to SwipeRx as a leading Indonesian health-tech player connecting pharmacies, healthcare professionals and patients, although Halodoc is more B2C while SwipeRx's commerce layer is B2B.
- Alodokter: One of Indonesia's largest health-information and digital health platforms with a community of doctors and content plus an online pharmacy feature. Comparable to SwipeRx as a leading Southeast Asian health professional network and pharmacy-adjacent commerce platform serving the same Indonesia-centric customer base.
Broad incumbents
- GoodRx: US-listed digital pharmacy platform connecting consumers with affordable prescriptions and a B2B pharma marketing business. Comparable to SwipeRx's two-sided model of pharmacy/customer reach monetized through pharma marketing and commerce, although it operates at much larger scale and in the US market.
Regional players
- PharmEasy: Indian online pharmacy and diagnostics platform serving consumers with medicine delivery and lab tests. Comparable to SwipeRx as a digital pharmacy commerce platform in an emerging Asian market, though it is primarily B2C and India-focused rather than a pharmacy-to-pharma B2B marketplace.
- Tata 1mg: India's leading digital pharmacy and health information platform (backed by Tata). Comparable as a vertically integrated digital pharmacy commerce platform, but operating in India and with a B2C consumer focus rather than SwipeRx's pharmacy professional community and B2B procurement model.
- Doctor Anywhere: Singapore-headquartered telehealth and digital health platform operating across Southeast Asia (Singapore, Malaysia, Thailand, Philippines, Vietnam, Indonesia). Comparable as a regional digital health platform overlapping SwipeRx's Southeast Asian footprint and pharmacy-adjacent services.
- mPharma: Africa-focused pharmacy management and wholesale procurement platform serving thousands of pharmacies across multiple African countries. Closely comparable to SwipeRx in business model (B2B pharmaceutical procurement + pharmacy services for retail pharmacies in emerging markets), though operating in a different geography.
Emerging players
- Kalo (KlikDokter): Indonesian employee health-benefits and corporate wellness platform that engages pharmacy and clinical provider networks. Comparable to SwipeRx as an emerging Indonesian health platform monetizing access to healthcare providers and pharmacies, although its primary model is B2B benefits rather than B2B pharma procurement.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
SwipeRx social profiles
Digital presenceSwipeRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
SwipeRx leadership team
Management profileNumber of profiles
Profiles7 records
SwipeRx funding detail
Funding detailFunding overview
Funding rounds5 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SwipeRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SwipeRx
What does SwipeRx do?
SwipeRx operates a mobile-first B2B commerce and professional community platform connecting 300,000+ pharmacy professionals and 50,000+ retail pharmacies across Southeast Asia with pharmaceutical manufacturers and suppliers. Its SwipeRx Belanja B2B e-commerce platform enables pharmacies to procure medicines and supplies with competitive pricing, promotions, flexible payment, and delivery, while the broader app delivers accredited CPD education, industry news, drug directory, case reporting, adverse event reporting, and peer collaboration for pharmacists.
Is SwipeRx a public or private company?
SwipeRx is a private company. It is classified as venture growth investor backed and is currently operating.
When was SwipeRx founded?
SwipeRx was founded in 2012. It employs 251 to 500 people.
Where is SwipeRx based?
SwipeRx is headquartered in Singapore, Singapore, in the Asia region.
How does SwipeRx make money?
Two revenue lines are on record. B2B Commerce Transaction Fees are the primary driver. The others are pharmaceutical Company Partnerships.
Who are SwipeRx's main competitors?
Direct peers on record are Halodoc and Alodokter. GoodRx is listed as a broad incumbent. Regional players are PharmEasy, Tata 1mg, Doctor Anywhere and mPharma. Kalo (KlikDokter) is listed as an emerging player.
Does SwipeRx have an API?
No public API is recorded for SwipeRx.
What industry is SwipeRx in?
SwipeRx's product category is Pharmacy B2B Commerce Platform. Its primary akta.pro industry code is BPAMAGAD, B2B Marketplaces & Wholesale Platforms, with a secondary code of HLAFALAL, 340B Program Administration & Contract Pharmacy Services. Its NAICS code is 45611 and its SIC code is 5122.